The slip
PARKINSON RECEIPTno. 12727
28 Oct 2026, 06:01 UTCdopamine neurons, braak
predictionCERS3 in dopamine neurons tracks Braak Lewy-body stage
registered155874789dd98901
discovery+0.52 p=0.151 n=9
replication+0.37 p=0.321 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.52, p 0.151)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTe2a07ea31d05b877f7290deb…
follows 4f361e31e881…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12727: CERS3 in dopamine neurons, braak
- power
- full sample +0.44 (p 0.066, n 18), 95% CI -0.03 to +0.75. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.48 (p 0.045, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.51 (p 0.029, n 18). not the mix.
- skeptic
- leave-one-out range +0.36 to +0.54, sign flips 0; without severely affected donors +0.44 (p 0.066, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CERS3 in dopamine neurons.
case closed: nothing better to follow up.